喀什阴道紧缩的手术喀什哪家治阳痿,喀什割包茎得花多少钱,喀什取环多久可以重新上环,喀什包皮手术风险有多大,喀什取环可以自己去吗,喀什切包皮会有影响吗,喀什男科医院男科医院哪家好

SEOUL, Aug. 31 (Xinhua) -- South Korea's infant mortality rate decreased by nearly half in the last 20 years to stand as the world's 16th lowest, a report showed Wednesday.South Korea had an infant mortality rate of 2.2 per 1,000 in 2009, compared with four deaths per 1,000 newborns reported in 1990, the World Health Organization (WHO) and Save the Children, an international non-governmental organization working for children's rights, said in a joint report.With a 45 percent decline in the infant mortality rate, South Korea ranked 16th lowest among WHO member countries, down from its 88th spot in 1990, according to the report. South Korea's infant mortality rate was the same as France, Estonia and Malta. Meanwhile, the Democratic People's Republic of Korea (DPRK) also showed a decline in the infant mortality rate from 23 per 1,000 in 1990 to 18.1 per 1,000 in 2009, but still remained in the lower ranks with 125th place.

MOSCOW, Aug. 30 (Xinhua) -- Russia's space agency said Tuesday that a Proton-M rocket launch failed earlier this month because of a malfunction in the upper stage.The conclusion was reached by an independent investigation commission following a series of checks, Roscosmos said in a report that was posted on its website."The commission reported that the time span reserved for the gyrostabilized platform's turn was miscalculated and narrowed, which caused the Briz-M upper stage's disorientation and the satellite's journey to a wrong orbit," the agency said.Other systems in the upper stage performed well, the agency said, adding it has lifted a ban on launches of the Proton-M carrier rockets equipped with the Briz-M upper stage.Local media reported the Briz-M, manufactured by the Khrunichev State Research and Production Space Center, has had five failures over its 12-year history of operation.On Aug. 18, a Proton-M carrier rocket failed to deliver a communications satellite into orbit. After the failure, Russia suspended launches of Proton-M rockets pending the outcome of an investigation into the failure.

HAVANA, Aug. 15 (Xinhua) -- Cuba's Ministry of Public Health launched an intensive sanitation campaign Monday against the Aedes Aegypti mosquito, which can spread dengue fever.The operation, which is running through Sept. 15, will cover the most vulnerable cities in the country, including the capital Havana and the eastern city Guantanamo.Deputy Health Minister Luis Estruch stressed the importance of the prevention campaign and urged all families to check their houses for mosquitoes each week.Maria Guadalupe Guzman, director of the Pan-American and World Health Organization Cooperation Center for the Study of Dengue and Its Vector at the Pedro Kouri Institute of Tropical Medicine, said the epidemiological situation in the country is stable. However, she warned that an epidemic outbreak is still possible in the island state, given the high temperatures and heavy rains in the eastern areas, and drought in the west.Cuba, along with Chile and Uruguay, are the only Latin American countries where dengue is not endemic.In 1981, the country suffered its worst dengue outbreak in history, which left 158 dead.

SYDNEY, July 15 (Xinhua) -- The world's first drug to increase life expectancy of people with advanced melanoma has been approved for use in Australia, local media reported on Friday.The breakthrough drug Yervoy got approval from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the most lethal form of skin cancer but for whom other treatments have failed, the Australian Associated Press (AAP) said.Clearance for the drug's use in Australia follows similar approvals by the U.S. health regulator in March.Yervoy works by attacking and destroying cancer cells.Patients are hooked up to an intravenous drip once every three weeks for a total of four doses.Professor Peter Hersey, consultant immunologist to the Melanoma Institute Australia, said no other drug had improved survival rates like Yervoy."Not all patients respond to it but those who do have a good chance of living longer than they would have otherwise," Hersey told AAP.While it may improve survival rates, Yervoy can produce side effects from diarrhea and vomiting to serious blood infections and kidney failure.The average survival time for people with advanced melanoma is just six months.A global study of 676 people with melanoma found that 45 percent of patients given Yervoy were still alive after one year, according to AAP.More than 20 percent lived at least two years, with a small number managing to survive for six years.A separate study, published in June, which showed similarly improved survival rates for patients with newly diagnosed advanced melanoma, has raised hopes that Yervoy could be made more widely available.Melanoma is the fourth most common cancer in Australia, with 10, 300 people diagnosed each year.

BEIJING, Sept. 26 (Xinhuanet) -- Young unmarried migrant women are facing a high risk of induced abortions in China and experts urged that they have better access to reproductive health education.Among the 8 to 10 million induced abortions performed on the mainland each year, nearly 47 percent involve unmarried women younger than 25, according to Cheng Linan, director of the center for clinical research and training of the Shanghai Institute of Planned Parenthood Research.The statistics are based on the results from a recent nationwide survey."The rising trend of induced abortions is even more evident among migrants who usually have poor awareness and access to reproductive health knowledge and services, particularly about contraception," she said on Saturday at an event to mark World Contraceptive Day, which falls on Sept 26.A 2008 survey involving more than 50,000 induced abortions in Beijing showed that roughly 70 percent of the women undergoing the procedure were migrants. For many, it was not their first abortion.According to a nationwide study by the Chinese Medical Association (CMA), of all women having received induced abortions, nearly 56 percent had two operations and 13.5 percent had three or more."That not only causes the women certain physical or mental problems, but it also gives the country a huge economic burden of more than 3 billion yuan" or about 0 million, she said.Among Chinese women who became infertile, more than 88 percent previously had an induced abortion, a study conducted in 2007 showed.Other potential health hazards include hemorrhage, uterine or pelvic infection, uterine perforation and cervical laceration.Apart from low awareness, poor access to professional consultations on contraception, particularly among single young women, is mainly the problem.A 2011 survey by the CMA found that about 44 percent of those polled said they had difficulty accessing scientifically correct contraceptive information, compared with a global average of 15.5 percent.